DK1853735T3 - Fremgangsmåder til detektering af progressionen af cervikal dysplasi i let grad - Google Patents
Fremgangsmåder til detektering af progressionen af cervikal dysplasi i let gradInfo
- Publication number
- DK1853735T3 DK1853735T3 DK06748239.8T DK06748239T DK1853735T3 DK 1853735 T3 DK1853735 T3 DK 1853735T3 DK 06748239 T DK06748239 T DK 06748239T DK 1853735 T3 DK1853735 T3 DK 1853735T3
- Authority
- DK
- Denmark
- Prior art keywords
- detecting
- progression
- methods
- patient
- cervical dysplasia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Paper (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65417605P | 2005-02-18 | 2005-02-18 | |
| PCT/US2006/006116 WO2006089287A2 (en) | 2005-02-18 | 2006-02-21 | Methods for detecting progression of low grade cervical dysplasia and for detecting adenocarcinomas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1853735T3 true DK1853735T3 (da) | 2011-05-16 |
Family
ID=36778261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06748239.8T DK1853735T3 (da) | 2005-02-18 | 2006-02-21 | Fremgangsmåder til detektering af progressionen af cervikal dysplasi i let grad |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8409808B2 (da) |
| EP (2) | EP2333117B1 (da) |
| JP (1) | JP5053867B2 (da) |
| AT (1) | ATE498023T1 (da) |
| AU (1) | AU2006213996B2 (da) |
| CA (1) | CA2598179A1 (da) |
| DE (1) | DE602006020021D1 (da) |
| DK (1) | DK1853735T3 (da) |
| ES (1) | ES2360954T3 (da) |
| HK (1) | HK1115166A1 (da) |
| WO (1) | WO2006089287A2 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100211066A1 (en) * | 2006-06-06 | 2010-08-19 | University Of Massachusetts | Use of IMP3 as a Prognostic Marker for Cancer |
| EP2078030A4 (en) * | 2006-10-25 | 2010-12-15 | Ikonisys Inc | AUTOMATED DETECTION OF CANCER AND HIGH-GRADE HYPERPLASIA |
| US20090208965A1 (en) * | 2006-10-25 | 2009-08-20 | Ikonisys, Inc. | Automated method for detecting cancers and high grade hyperplasias |
| WO2010011683A2 (en) | 2008-07-21 | 2010-01-28 | Neodiagnostix, Inc. | Methods for the cytological analysis of cervical cells |
| WO2011011527A2 (en) | 2009-07-21 | 2011-01-27 | Neodiagnostix, Inc. | Method and system for automated image analysis in cancer cells |
| US8865882B2 (en) | 2010-09-08 | 2014-10-21 | Cancer Genetics, Inc. | Methods for detecting human papilloma virus-associated cancers |
| JP6685229B2 (ja) * | 2014-02-17 | 2020-04-22 | シエナ キャンサー ダイアグノスティクス リミテッドＳｉｅｎｎａ Ｃａｎｃｅｒ Ｄｉａｇｎｏｓｔｉｃｓ Ｌｔｄ | 癌を検出する方法 |
| US20180238891A1 (en) * | 2015-08-19 | 2018-08-23 | Sienna Cancer Diagnostics Ltd | Cancer Detection Method |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756696A (en) | 1986-01-16 | 1998-05-26 | Regents Of The University Of California | Compositions for chromosome-specific staining |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| AU647741B2 (en) | 1989-12-01 | 1994-03-31 | Regents Of The University Of California, The | Methods and compositions for chromosome-specific staining |
| US5491224A (en) | 1990-09-20 | 1996-02-13 | Bittner; Michael L. | Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture |
| US5472842A (en) | 1993-10-06 | 1995-12-05 | The Regents Of The University Of California | Detection of amplified or deleted chromosomal regions |
| US5830645A (en) | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
| US5919624A (en) | 1997-01-10 | 1999-07-06 | The United States Of America As Represented By The Department Of Health & Human Services | Methods for detecting cervical cancer |
| US20040248107A1 (en) * | 2003-06-09 | 2004-12-09 | Sokolova Irina A. | Detection of high grade dysplasia in cervical cells |
-
2006
- 2006-02-21 US US11/884,608 patent/US8409808B2/en not_active Expired - Fee Related
- 2006-02-21 AU AU2006213996A patent/AU2006213996B2/en not_active Ceased
- 2006-02-21 DK DK06748239.8T patent/DK1853735T3/da active
- 2006-02-21 CA CA002598179A patent/CA2598179A1/en not_active Abandoned
- 2006-02-21 ES ES06748239T patent/ES2360954T3/es active Active
- 2006-02-21 DE DE602006020021T patent/DE602006020021D1/de active Active
- 2006-02-21 WO PCT/US2006/006116 patent/WO2006089287A2/en active Application Filing
- 2006-02-21 EP EP10185965.0A patent/EP2333117B1/en not_active Not-in-force
- 2006-02-21 EP EP06748239A patent/EP1853735B1/en not_active Not-in-force
- 2006-02-21 JP JP2007556404A patent/JP5053867B2/ja not_active Expired - Fee Related
- 2006-02-21 AT AT06748239T patent/ATE498023T1/de not_active IP Right Cessation
-
2008
- 2008-04-30 HK HK08104794.2A patent/HK1115166A1/xx not_active IP Right Cessation
-
2013
- 2013-04-01 US US13/854,764 patent/US20140005063A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006089287A2 (en) | 2006-08-24 |
| US20090035763A1 (en) | 2009-02-05 |
| ES2360954T3 (es) | 2011-06-10 |
| EP1853735A2 (en) | 2007-11-14 |
| ATE498023T1 (de) | 2011-02-15 |
| EP2333117A1 (en) | 2011-06-15 |
| EP1853735B1 (en) | 2011-02-09 |
| DE602006020021D1 (de) | 2011-03-24 |
| JP2008530998A (ja) | 2008-08-14 |
| JP5053867B2 (ja) | 2012-10-24 |
| EP2333117B1 (en) | 2013-10-16 |
| HK1115166A1 (en) | 2008-11-21 |
| AU2006213996A1 (en) | 2006-08-24 |
| US20140005063A1 (en) | 2014-01-02 |
| US8409808B2 (en) | 2013-04-02 |
| CA2598179A1 (en) | 2006-08-24 |
| WO2006089287A3 (en) | 2006-12-14 |
| AU2006213996B2 (en) | 2011-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1853735T3 (da) | Fremgangsmåder til detektering af progressionen af cervikal dysplasi i let grad | |
| DK1721992T3 (da) | Fremgangsmåder og nukleinsyrer til analyser af cellulære proliferative sygdomme | |
| ATE531820T1 (de) | Gesundheitszustandstest | |
| ATE430936T1 (de) | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome | |
| DK1463839T3 (da) | Fremgangsmåde til detektering af human papillomavirus mRNA | |
| EP1838867A4 (en) | APOLIPOPROTEIN A-II ISOFORM USED AS BIOMARKER FOR PROSTATE CANCER | |
| WO2006137932A3 (en) | Homogeneous analyte detection | |
| DK1812590T3 (da) | Fremgangsmåder og reagenser til detektering af melanomer | |
| DK1948816T3 (da) | Forbedrede fremgangsmåder til beaming | |
| WO2006128192A3 (en) | Use of free circulating dna for diagnosis, prognosis, and treatment of cancer | |
| ATE457362T1 (de) | Mrna-verhältnisse in harnsedimenten und/oder harn als prognostische und/oder theranostische marker für prostatakrebs | |
| DK1871912T3 (da) | Fremgangsmåde til bestemmelse af DNA-methylering i blod- eller urinprøver | |
| ATE536553T1 (de) | Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse | |
| ATE486285T1 (de) | Verfahren zur früherkennung von krebs | |
| MY150648A (en) | Hla alleles associated with adverse drug reactions and methods for detecting such | |
| DK2258871T3 (da) | Fremgangsmåder og nukleinsyrer til analyse af celleproliferative lidelser | |
| DK1515752T3 (da) | ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension | |
| ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| DK1721162T3 (da) | Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A | |
| CA2701341A1 (en) | Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex | |
| DE602005013633D1 (de) | Vorrichtung zur Detektion von atmosphärischer Turbulenz | |
| WO2004057336A3 (en) | Use of nicotinamide n-methyltransferase as a marker for colorectal cancer | |
| ATE504833T1 (de) | Verfahren zur bestimmung des phänotyps von zellen | |
| WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
| BR0314155A (pt) | Métodos para diagnosticar câncer cervical |